* Seattle genetics inc reports a 8.2 percent stake in immunomedics inc as of June 29, 2017 - sec filing

* Seattle Genetics- acquired common stock, warrant in connection with development, license agreement with issuer to acquire strategic interest in Immunomedics Source text (bit.ly/2tyWqBp) Further company coverage: